Stefan K Zollner
Overview
Explore the profile of Stefan K Zollner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kerkhoff M, Grunewald S, Schaefer C, Zollner S, Plaumann P, Busch M, et al.
Bioengineering (Basel)
. 2023 Apr;
10(4).
PMID: 37106651
Resection margin adequacy plays a critical role in the local control of sarcomas. Fluorescence-guided surgery has increased complete resection rates and local recurrence-free survival in several oncological disciplines. The purpose...
2.
Zollner S, Kauertz K, Kaiser I, Kerkhoff M, Schaefer C, Tassius M, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497417
Ewing sarcoma (EwS) is the second most common bone and soft tissue tumor, affecting primarily adolescents and young adults. Patients with secondary EwS are excluded from risk stratification in several...
3.
Kaiser I, Kauertz K, Zollner S, Hartmann W, Langer T, Jurgens H, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497401
Ewing sarcoma (EwS) represents highly aggressive bone and soft tissue tumors that require intensive treatment by multi-chemotherapy, surgery and/or radiotherapy. While therapeutic regimens have increased survival rates, EwS survivors face...
4.
Graham G, Selvanathan S, Zollner S, Stahl E, Shlien A, Caplen N, et al.
NAR Cancer
. 2022 Jan;
4(1):zcab052.
PMID: 35047826
Ewing sarcoma (EwS) is a small round blue cell tumor and is the second most frequent pediatric bone cancer. 85% of EwS tumors express the fusion oncoprotein EWS-FLI1, the product...
5.
Zollner S, Kampmeier S, Frobose N, Herbruggen H, Masjosthusmann K, van den Heuvel A, et al.
Front Oncol
. 2021 Oct;
11:752037.
PMID: 34712613
is an important nosocomial pathogen in immunocom-promised individuals and characterized by intrinsic resistance to broad-spectrum antibacterial agents. Limited data exists on its clinical relevance in immunocompromised pediatric patients, particularly those...
6.
Zollner S, Amatruda J, Bauer S, Collaud S, de Alava E, Dubois S, et al.
J Clin Med
. 2021 Apr;
10(8).
PMID: 33919988
Ewing sarcoma, a highly aggressive bone and soft-tissue cancer, is considered a prime example of the paradigms of a translocation-positive sarcoma: a genetically rather simple disease with a specific and...
7.
Willmer D, Zollner S, Schaumburg F, Jurgens H, Lehrnbecher T, Groll A
Cancers (Basel)
. 2021 Apr;
13(9).
PMID: 33919049
The purpose of this retrospective, single-center cohort study was to assess the infectious burden in pediatric sarcoma patients during neoadjuvant chemotherapy. The review included all patients with a new diagnosis...
8.
Zollner S, Herbruggen H, Kolve H, Mihailovic N, Schubert F, Reicherts C, et al.
Transpl Infect Dis
. 2019 Apr;
21(5):e13089.
PMID: 30972869
Cytomegalovirus retinitis (CMVR) may occur after allogeneic hematopoietic stem cell transplantation (HSCT). However, little is known about its incidence, strategies for ophthalmic surveillance, and timely implementation of adequate antiviral treatment...
9.
Zollner S, Selvanathan S, Graham G, Commins R, Hong S, Moseley E, et al.
Sci Signal
. 2017 Oct;
10(499).
PMID: 28974650
Ewing's sarcoma (ES) is a rare and highly malignant cancer that grows in the bones or surrounding tissues mostly affecting adolescents and young adults. A chimeric fusion between the RNA...
10.
Zollner S, Rossig C, Toretsky J
Cancer Metastasis Rev
. 2015 Aug;
34(3):417-28.
PMID: 26277104
Patients afflicted with synovial sarcoma share the fate of other translocation positive sarcomas; the driver mutation for this cancer is known, yet no means to target the fusion protein SS18-SSX...